Growth Metrics

Fulgent Genetics (FLGT) Current Leases (2019 - 2026)

Fulgent Genetics' Current Leases history spans 8 years, with the latest figure at $1.9 million for Q1 2026.

  • On a quarterly basis, Current Leases rose 45.26% to $1.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.9 million, a 45.26% increase, with the full-year FY2025 number at $1.5 million, up 1.32% from a year prior.
  • Current Leases hit $1.9 million in Q1 2026 for Fulgent Genetics, up from $1.5 million in the prior quarter.
  • Over the last five years, Current Leases for FLGT hit a ceiling of $6.1 million in Q4 2022 and a floor of $1.2 million in Q2 2025.
  • Historically, Current Leases has averaged $2.3 million across 5 years, with a median of $1.5 million in 2025.
  • Biggest five-year swings in Current Leases: crashed 63.53% in 2024 and later soared 45.26% in 2026.
  • Tracing FLGT's Current Leases over 5 years: stood at $6.1 million in 2022, then crashed by 35.47% to $4.0 million in 2023, then crashed by 63.53% to $1.4 million in 2024, then rose by 1.32% to $1.5 million in 2025, then surged by 32.15% to $1.9 million in 2026.
  • Business Quant data shows Current Leases for FLGT at $1.9 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.